1,198
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Paeoniflorin suppresses the apoptosis and inflammation of human coronary artery endothelial cells induced by oxidized low-density lipoprotein by regulating the Wnt/β-catenin pathway

, &
Pages 1454-1461 | Received 02 Aug 2022, Accepted 27 May 2023, Published online: 06 Sep 2023

References

  • Akyuz A. 2020. Exercise and coronary heart disease. Adv Exp Med Biol. 1228:169–179.
  • Bhasin M, Yuan L, Keskin DB, Otu HH, Libermann TA, Oettgen P. 2010. Bioinformatic identification and characterization of human endothelial cell-restricted genes. BMC Genomics. 11:342.
  • Chen H, Dong Y, He X, Li J, Wang J. 2018. Paeoniflorin improves cardiac function and decreases adverse postinfarction left ventricular remodeling in a rat model of acute myocardial infarction. Drug Des Devel Ther. 12:823–836.
  • Chen L, Zheng J, Xue Q, Zhao Y. 2019. YKL-40 promotes the progress of atherosclerosis independent of lipid metabolism in apolipoprotein E mice fed a high-fat diet. Heart Vessels. 34(11):1874–1881.
  • Efe D, Aygün F, Ulucan Ş, Keser A. 2015. Relationship of coronary artery disease with pericardial and periaortic adipose tissue and their volume detected by MSCT. Hellenic J Cardiol. 56:44–54.
  • Fioranelli M, Bottaccioli AG, Bottaccioli F, Bianchi M, Rovesti M, Roccia MG. 2018. Stress and inflammation in coronary artery disease: a review psychoneuroendocrineimmunology-based. Front Immunol. 9:2031.
  • Fruchart JC, Duriez P. 2002. HDL and triglyceride as therapeutic targets. Curr Opin Lipidol. 13(6):605–616.
  • Guo Y, Zhao Y, Li L, Wei X, Gao P, Zhou Y, Liu Y, Yang H. 2017. Concentration-dependent effects of paeoniflorin on proliferation and apoptosis of vascular smooth muscle cells. Mol Med Rep. 16(6):9567–9572.
  • Han F, Zhou D, Yin X, Sun Z, Han J, Ye L, Zhao W, Zhang Y, Wang Z, Zheng L. 2016. Paeoniflorin protects diabetic mice against myocardial ischemic injury via the transient receptor potential vanilloid 1/calcitonin gene-related peptide pathway. Cell Biosci. 6:37.
  • Hansson GK, Hermansson A. 2011. The immune system in atherosclerosis. Nat Immunol. 12(3):204–212.
  • Hu Y, Xu R, He Y, Zhao Z, Mao X, Lin L, Hu J. 2020. Downregulation of microRNA-106a-5p alleviates ox-LDL-mediated endothelial cell injury by targeting STAT3. Mol Med Rep. 22(2):783–791.
  • Ikonomidis I, Michalakeas CA, Parissis J, Paraskevaidis I, Ntai K, Papadakis I, Anastasiou-Nana M, Lekakis J. 2012. Inflammatory markers in coronary artery disease. Biofactors. 38(5):320–328.
  • Jang J, Jung Y, Chae S, Bae T, Kim SM, Shim YJ, Chung SI, Yoon Y. 2019. XAV939, a Wnt/β-catenin pathway modulator, has inhibitory effects on LPS-induced inflammatory response. Immunopharmacol Immunotoxicol. 41(3):394–402.
  • Lala A, Desai AS. 2014. The role of coronary artery disease in heart failure. Heart Fail Clin. 10(2):353–365.
  • Li H, Jiao Y, Xie M. 2017. Paeoniflorin ameliorates atherosclerosis by suppressing TLR4-mediated NF-kappaB activation. Inflammation. 40(6):2042–2051.
  • Liu B, Zhou H, Zhang T, Gao X, Tao B, Xing H, Zhuang Z, Dardik A, Kyriakides TR, Goodwin JE. 2021. Loss of endothelial glucocorticoid receptor promotes angiogenesis via upregulation of Wnt/β-catenin pathway. Angiogenesis. 24(3):631–645.
  • Liu Y, Neogi A, Mani A. 2020. The role of Wnt signalling in development of coronary artery disease and its risk factors. Open Biol. 10(10):200128.
  • Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. 2019. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 234(10):16812–16823.
  • Ma B, Hottiger MO. 2016. Crosstalk between Wnt/β-catenin and NF-κB signaling pathway during inflammation. Front Immunol. 7:378.
  • Narula N, Olin JW, Narula N. 2020. Pathologic disparities between peripheral artery disease and coronary artery disease. Arterioscler Thromb Vasc Biol. 40(9):1982–1989.
  • National Research Council, Division on Earth and Life Studies, Institute for Laboratory Animal Research, Committee for the Update of the Guide for the Care and Use of Laboratory Animals. 2010. Guide for the care and use of laboratory animals: eighth edition. Washington, DC: The National Academies Press.
  • Shang QH, Xu H, Lu XY, Wen C, Shi DZ, Chen KJ. 2011. A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients. Chin J Integr Med. 17(9):669–674.
  • Song CL, Liu B, Shi YF, Liu N, Yan YY, Zhang JC, Xue X, Wang JP, Zhao Z, Liu JG, et al. 2016. MicroRNA-130a alleviates human coronary artery endothelial cell injury and inflammatory responses by targeting PTEN via activating PI3K/Akt/eNOS signaling pathway. Oncotarget. 7(44):71922–71936.
  • Sturtzel C. 2017. Endothelial cells. Adv Exp Med Biol. 1003:71–91.
  • Tan W, Qiu Y, Chen N, Gao J, Liang J, Liu Y, Zhao D. 2021. The intervention of intestinal Wnt/β-catenin pathway alters inflammation and disease severity of CIA. Immunol Res. 69(4):323–333.
  • Tang H, Wu L, Chen X, Li H, Huang B, Huang Z, Zheng Y, Zhu L, Geng W. 2021. Paeoniflorin improves functional recovery through repressing neuroinflammation and facilitating neurogenesis in rat stroke model. Peer J. 9:e10921.
  • Tang Y, Zhao J, Shen L, Jin Y, Zhang Z, Xu G, Huang X. 2016. ox-LDL induces endothelial dysfunction by promoting Arp2/3 complex expression. Biochem Biophys Res Commun. 475(2):182–188.
  • Taskinen MR. 2003. LDL-cholesterol, HDL-cholesterol or triglycerides–which is the culprit? Diabetes Res Clin Pract. 61:S19–S26.
  • Tousoulis D, Economou EK, Oikonomou E, Papageorgiou N, Siasos G, Latsios G, Kokkou E, Mourouzis K, Papaioannou S, Deftereos S, et al. 2015. The role and predictive value of cytokines in atherosclerosis and coronary artery disease. Curr Med Chem. 22(22):2636–2650.
  • Trpkovic A, Resanovic I, Stanimirovic J, Radak D, Mousa SA, Cenic-Milosevic D, Jevremovic D, Isenovic ER. 2015. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases. Crit Rev Clin Lab Sci. 52(2):70–85.
  • Wang L, Li HC, Zhou J, Yang B, Qiao CD, Liu YM, Zhang Z. 2018. Correlation between the GP78 gene polymorphism and coronary atherosclerotic heart disease. Hellenic J Cardiol. 59(1):8–13.
  • Weerackoon N, Gunawardhana KL, Mani A. 2021. Wnt signaling cascades and their role in coronary artery health and disease. J Cell Signal. 2:52–62.
  • Williams H, Slater S, George SJ. 2016. Suppression of neointima formation by targeting beta-catenin/TCF pathway. Biosci Rep. 36:e00427.
  • Wu F, Ye B, Wu X, Lin X, Li Y, Wu Y, Tong L. 2020. Paeoniflorin on rat myocardial ischemia reperfusion injury of protection and mechanism research. Pharmacology. 105(5-6):281–288.
  • Xiang Y, Zhang Q, Wei S, Huang C, Li Z, Gao Y. 2020. Paeoniflorin: a monoterpene glycoside from plants of Paeoniaceae family with diverse anticancer activities. J Pharm Pharmacol. 72(4):483–495.
  • Xie P, Cui L, Shan Y, Kang WY. 2017. Antithrombotic effect and mechanism of radix Paeoniae rubra. Biomed Res Int. 2017:9475074.
  • Xin Q, Yuan R, Shi W, Zhu Z, Wang Y, Cong W. 2019. A review for the anti-inflammatory effects of paeoniflorin in inflammatory disorders. Life Sci. 237:116925.
  • Yang HO, Ko WK, Kim JY, Ro HS. 2004. Paeoniflorin: an antihyperlipidemic agent from Paeonia lactiflora. Fitoterapia. 75(1):45–49.
  • Yu M, Peng L, Liu P, Yang M, Zhou H, Ding Y, Wang J, Huang W, Tan Q, Wang Y, et al. 2020. Paeoniflorin ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition. Drug Des Devel Ther. 14:1191–1202.
  • Zhang L, Cheng H, Yue Y, Li S, Zhang D, He R. 2018. H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/beta-catenin in ox-LDL-stimulated vascular smooth muscle cells. J Biomed Sci. 25(1):11.
  • Zhao C, Zhang J, Ma L, Wu H, Zhang H, Su J, Geng B, Yao Q, Zheng J. 2020. GOLPH3 Promotes angiogenesis of lung adenocarcinoma by regulating the Wnt/β-catenin signaling pathway. Onco Targets Ther. 13:6265–6277.
  • Zhou Y, Wang Y, Tischfield M, Williams J, Smallwood PM, Rattner A, Taketo MM, Nathans J. 2014. Canonical WNT signaling components in vascular development and barrier formation. J Clin Invest. 124(9):3825–3846.